A NOVEL, DIRECT NO DONOR REGULATES OSTEOBLAST AND OSTEOCLAST FUNCTIONS AND INCREASES BONE MASS IN OVARIECTOMIZED MICE

Most FDA-approved treatments for osteoporosis target osteoclastic bone resorption. Only PTH derivatives improve bone formation, but they have drawbacks, and novel bone-anabolic agents are needed. Nitrates, which generate NO, improved BMD in estrogen-deficient rats and may improve bone formation mark...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Bone Miner Res
Autori principali: Kalyanaraman, Hema, Ramdani, Ghania, Joshua, Jisha, Schall, Nadine, Boss, Gerry R., Cory, Esther, Sah, Robert L., Casteel, Darren E., Pilz, Renate B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5199609/
https://ncbi.nlm.nih.gov/pubmed/27391172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2909
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi